Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 1,216 All time
- Disclosed funding
- $109.5B 708 disclosed amounts
- Median round
- $10.3M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| A AlphyCompany profile Builds AI-powered communication risk detection for financial services and legal industries Builds AI-powered communication risk detection for financial services and legal industries | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors | |
| M AI-native audit technology platform for accounting firms | $85M | Seed+Series AUndisclosed | Fintech | United States | Investors | |
| TB AI-powered returns processing technology platform for logistics and retail | $3.2M | Undisclosed | Ecommerce | United States | Investors | |
| NA NeuBird AICompany profile Builds agentic AI for enterprise IT operations that automates incident detection and root cause analysis Builds agentic AI for enterprise IT operations that automates incident detection and root cause analysis | $19.3M | Undisclosed | AI | United States | Investors | |
| M Provides real-time control over AI behavior for organizations | $12M | Undisclosed | AI | United States | Investors | |
| A AccuQuantCompany profile AI and data-analysis infrastructure for automated decision-making in financial applications. AI and data-analysis infrastructure for automated decision-making in financial applications. | $20M | Undisclosed | Fintech | United Kingdom | Investors Undisclosed | |
| D Dossier makes fragrances. | Undisclosed | StrategicUndisclosed | Consumer | United States | Investors | |
| F Develops biotech-powered hair supplements using proprietary microencapsulation | Undisclosed | Follow-OnUndisclosed | Biotech | United Kingdom | Investors | |
| S StairMedCompany profile Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases | CN¥500M | StrategicUndisclosed | Healthtech | China | Investors | |
| A Develops real-time nervous system regulation tools | $1.9M | Undisclosed | Healthtech | Finland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1EU Innovation Fund
Epyr, Reverion, H2SITE
18rounds0led - 2NVIDIA
Riverlane, Foresight, Hiverge
14rounds0led - 3Accel
Coast, Origin, Scimplify
12rounds3led - 4Andreessen Horowitz (a16z)
Conway Research, EliseAI, Thatch
12rounds2led - 5Innovate UK
Emerald, Go Eve, Adaptavate
10rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.